Shanghai Hile Bio-tech Cash Flow Quality Index
Shanghai Hile Bio-tech cash flow quality index. Shanghai Hile Bio-tech (603718) has a Cash Flow Quality Index of -0.57x as of September 2025. Operating cash flow of CN¥-1.18 Million is below net income of CN¥2.09 Million, suggesting accrual-heavy earnings not yet converted to cash. See Shanghai Hile Bio-tech leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Shanghai Hile Bio-tech (2011–2024)
Cash flow quality index of Shanghai Hile Bio-tech from 2011 to 2024. Historical Cash Flow Quality Index for Shanghai Hile Bio-tech across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore how well can Shanghai Hile Bio-tech service its debt to assess how comfortably operating cash covers total debt obligations.
Shanghai Hile Bio-tech Cash Flow Quality Index by Year (2011–2024)
Shanghai Hile Bio-tech cash flow quality index by year from 2011 to 2024. Year-by-year earnings quality comparison for Shanghai Hile Bio-tech. For the full cash flow conversion analysis, see 603718 cash flow conversion.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.27x | CN¥46.47 Million | CN¥171.18 Million | ▲ +562.1% |
| 2023 | -0.06x | CN¥-2.94 Million | CN¥50.01 Million | ▼ -102.2% |
| 2022 | 2.65x | CN¥292.91 Million | CN¥110.69 Million | ▲ +176.9% |
| 2021 | 0.96x | CN¥43.63 Million | CN¥45.67 Million | ▲ +160.7% |
| 2017 | 0.37x | CN¥34.92 Million | CN¥95.29 Million | ▼ -76.3% |
| 2016 | 1.55x | CN¥108.39 Million | CN¥70.05 Million | ▼ -29.9% |
| 2015 | 2.21x | CN¥201.69 Million | CN¥91.33 Million | ▲ +100.0% |
| 2014 | 1.10x | CN¥110.22 Million | CN¥99.84 Million | ▼ -11.4% |
| 2013 | 1.25x | CN¥147.63 Million | CN¥118.42 Million | ▲ +14.6% |
| 2012 | 1.09x | CN¥122.48 Million | CN¥112.55 Million | ▼ -22.0% |
| 2011 | 1.39x | CN¥149.61 Million | CN¥107.27 Million | — |